What an Investment Committee Process Actually Reviews

An investment committee, or IC, is the internal body at a fund manager that reviews and approves deals before capital goes out the door. A real IC process checks the deal thesis, valuation, risk, structure, and how it fits the fund's mandate — and it does this with people who did not originate the deal, so the review is not just the same person approving their own idea. Whether a manager has this process at all, and whether it is real rather than nominal, is one of the clearer governance signals available before you look at any specific deal or return figure.

What an Investment Committee Is

An investment committee is a formal decision-making body inside a fund manager, distinct from the individual deal team that sources and negotiates an opportunity. Its role is to review proposed investments against the fund's stated strategy and risk parameters, and to approve, reject, or send back deals before capital is committed.

The core idea behind an IC is separation of duties. The people who find and champion a deal are not the same people who have final authority to approve it. This separation exists because deal sponsors are naturally motivated to see their own deal succeed — an independent review layer is meant to catch problems a sponsor's enthusiasm might miss.

IC structures vary. Some managers have a small, formal IC with named members and documented votes. Others use a looser internal review that is not always called an "investment committee" but performs a similar function. What matters for evaluating a manager is not the label, but whether an independent review actually happens before capital is committed — and that connects directly to the broader manager due diligence process; see manager due diligence for RWA products for how IC process fits into a fuller evaluation.

What the IC Reviews Before Approving a Deal

A functioning IC process typically works through a consistent set of questions before signing off on a deal, regardless of asset type. The specifics differ between a private credit loan and a pre-IPO equity stake, but the categories of review are similar.

Two elements matter more than they might first appear: valuation review and downside scenario analysis. Valuation review exists because private assets do not have a market price to check against — a related topic covered in how non-listed assets get priced. Downside scenario analysis exists because a deal thesis alone only describes the upside case; a real IC process asks what happens if the thesis is wrong, not only what happens if it is right.

How IC Composition and Independence Affect the Review

Not every IC provides the same quality of check. Composition and independence determine how meaningful the review actually is.

A few structural questions separate a substantive process from a formality:

• Does the IC include people who are not part of the deal-sourcing team, or is it effectively the same people approving their own work?
• Are there external or independent members — outside advisors, non-executive directors, or similar — who have no personal stake in the deal being approved?
• Is there a documented voting or approval record, or is approval informal and undocumented?
• Can the IC actually reject or modify a deal, or does it function as a rubber stamp for decisions already made?

A single-person "committee," or a committee made up entirely of the deal team itself, does not provide the separation of duties an IC is meant to deliver. This is closely related to whether the manager has personal capital at risk in the fund — see why GP commitment matters for how manager alignment interacts with governance quality more broadly.

Why the Existence of a Real IC Process Is a Governance Signal

Whether a manager has a real IC process — and whether they can describe it specifically — tells you something about how deals get approved even when you cannot see the deliberations themselves.

A manager who can describe their IC process concretely (who sits on it, what triggers a review, what documentation is produced, how often it meets) is demonstrating that the process exists as an operational fact, not just as a line in a pitch deck. A manager who cannot answer these questions specifically, or who describes approval as informal or ad hoc, is signaling that deals may be approved with less structured scrutiny than the marketing materials imply.

This matters independently of how any individual deal performs. A strong IC process does not guarantee good outcomes — a well-reviewed deal can still lose money, and a deal approved informally can still perform well. What the IC process indicates is discipline: whether the manager has a repeatable way of catching problems before capital goes out, which affects the distribution of outcomes over many deals, not the certainty of any single one.

What to Ask When a Product Mentions an Investment Committee

When an RWA product's materials reference an investment committee or similar approval process, a few direct questions help separate substance from mention:

1. Who sits on the IC, and are any members independent of the deal-sourcing team?
2. What specifically does the IC review — valuation, structure, concentration, downside scenarios — or is the description generic?
3. Is there a documented approval record for deals, or is the process undocumented?
4. Can you name a deal the IC rejected or sent back? A process that has never said no is harder to evaluate as independent.
5. How does the IC process connect to the fund's stated mandate limits, and who monitors whether approved deals stay within them?

If an offering document or manager presentation mentions an investment committee only in passing, with no detail on composition or process, treat that the same way you would treat any other vague claim in an offering document — as something to verify rather than accept. Red flags to check in an RWA offering document and how to background-check an RWA issuer or manager both cover complementary ground: verifying claims that appear in a manager's materials rather than taking them at face value. You can review manager and product documentation for listed RWA offerings at BiFu RWA.

FAQ

What is the purpose of an investment committee in a fund?

An investment committee exists to review and approve deals independently of the team that sourced them, checking the thesis, valuation, risk, and structure before capital is committed. The separation between the people who find a deal and the people who approve it is meant to catch problems that a deal sponsor's own enthusiasm might miss.

Does every fund manager have a formal investment committee?

No. Some managers have a small, formal IC with documented votes, while others use a looser internal review process that is not always labeled an investment committee. What matters more than the label is whether an independent review of each deal actually happens before capital is committed.

How can I tell if an investment committee is real or just a formality?

Ask who sits on it, whether any members are independent of the deal-sourcing team, whether approvals are documented, and whether the manager can point to a deal the committee rejected or modified. A committee made up entirely of the same people who source deals, with no documented record, functions more as a formality than an independent check.

Does a strong investment committee process guarantee a deal will perform well?

No. A well-reviewed deal can still underperform or default, because an IC process reduces the chance of avoidable mistakes rather than eliminating market, credit, or execution risk. It is a governance signal about discipline and process, not a predictor of any single deal's outcome.

This content is for educational purposes only and does not constitute financial, investment, legal, tax, or trading advice. RWA products involve risk, including possible loss of principal. Always review product documents and risk disclosures before participating.

Related Reading

• Manager due diligence for RWA: mandate, controls, and reporting
• How to background-check an RWA issuer or manager
• Why GP commitment matters: does the manager have skin in the game?